Monte Rosa Therapeutics, Inc. (GLUE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.03B |
| Enterprise Value | 937.03M |
| P/E Ratio | -6.56 |
| PEG Ratio | 0.8 |
| Price/Sales Ratio | 42.05 |
| Price/Book Ratio | 2.5 |
| Enterprise/Revenue | 40.24 |
| Enterprise/EBITDA | -7.42 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -5.61 |
| Operating Margin | -6.33 |
AD
Management Effectiveness
| Return On Assets | -0.23 |
| Return On Equity | -0.43 |
Income Statement
| Revenue | 123.67M |
| Revenue/Share | 0.34 |
| Gross Profit | 115.32M |
| EBITDA | -31.37M |
| Net Income | -38.63M |
| Diluted EPS | -0.59 |
Balance Sheet
| Total Cash | 621.1M |
| Total Cash/Share | 7.29 |
| Total Debt | 37.99M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 9.52 |
| Book Value Per Share | 5.69 |
Price History
| 52-Week Change | 196.68 |
| 52-Week High | 25.77 |
| 52-Week Low | 4.54 |
| Moving Average 50 Days | 19.98 |
| Moving Average 200 Days | 18.49 |
Statistics
| Average Volume | 1.41M |
| Shares Outstanding | 84.48M |
| % Held by Institutions | 142.23 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
